Brief: Spectral AI Expands Clinical Trial Sites For Pivotal US Burn Study
03/07/2024 13:20
July 3 (Reuters) - Spectral AI Inc MDAI.O :
* SPECTRAL AI EXPANDS CLINICAL TRIAL SITES FOR PIVOTAL U.S.
BURN
STUDY
* SPECTRAL AI INC - ADDS TWO NEW U.S. CLINICAL TRIAL SITES
* SPECTRAL AI INC - BURN PIVOTAL STUDY TO BE COMPLETED IN Q4
2024
Source text for Eikon: ID:nGNX8BNZWH
Further company coverage: MDAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectral AI
See all newsSpectral AI Inc reports results for the quarter ended June 30 - Earnings Summary
Spectral AI Inc expected to post a loss of 13 cents a share - Earnings Preview
Brief: Spectral Ai Receives FDA De Novo Clearance For Deepview® System For Burn Indication
Brief: Spectral Ai Inc - Forecasts Fy2026 Revenue Of About $18.5 Million
Brief: Spectral Ai Names David Mcguire, Cpa, As Chief Financial Officer